StockMirror — Stock Screener

SHARDACROP Q4 FY26 Results & Earnings Analysis

Sentiment: Good (Confidence: high)

Earnings Summary

Sharda Cropchem reported its best-ever financial performance in FY26 with 22% revenue growth, 600 bps gross margin expansion, 69% EBITDA growth, and 124% PAT growth. The company remains debt-free with INR 702 crores in cash. FY27 guidance is slightly cautious at 10-15% revenue growth and 18-20% EBITDA margins, with volume growth expected around 15%. The registration moat (3,011 registrations, 1,004 in pipeline) and diversified presence in 70+ countries provide competitive advantages. Key risks include geopolitical uncertainties, forex volatility, and regulatory delays in registrations. ,,

Management Tone

Revenue Growth Drivers

Growth vs Margin Focus

Management guided for 10-15% revenue growth while maintaining 18-20% EBITDA margins and ~35% gross margins, indicating balanced focus. ,

About Sharda Cropchem Limited

Sharda Cropchem Limited (SHARDACROP) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.

Explore More